The Importance of Supplier Qualification of the Full Distribution Life-cycle in Pharmaceuticals

Size: px
Start display at page:

Download "The Importance of Supplier Qualification of the Full Distribution Life-cycle in Pharmaceuticals"

Transcription

1 The Importance of Supplier Qualification of the Full Distribution Life-cycle in Pharmaceuticals William Dale Carter IPEC Americas Chair-Elect & GMP Committee Chair ExcipientFest April 25,

2 Challenges in Today s Excipient Supply Chain Diversity in locations and sourcing strategies has created a maze of supply routes for ingredients Increased awareness of supply chain vulnerability Closure of a manufacturing facility Raw material/feedstock issues Terrorism/fraud Increased interest in alternate sources of excipients New developments in regulation, compliance, testing and innovation have forced the pharmaceutical industry to pay more attention to excipients

3 2007 Action Plan for Import Safety USA - Report to the President Interagency Working Group on Import Safety November 2007

4 Excipient Supply Chain Drug Product consumed by patient Excipients used in making the drug product Received, inspected and released Delivered to Drug Product Manufacturer Excipient Transportation and Distribution Export Import Storage - Repackaging Excipient initial storage and packaging Manufacturing of bulk excipient Sourcing of raw materials to make excipient

5 Goal is to Manage Risk Risk to Both Drug Maker & to Patient Quality of excipient causes failure of drug batch during Manufacturing Availability of drug Product Quality of excipient causes failure of drug in use or results in hazardous product 21 CFR (a)(9) 21 CFR 330.1(e) 5

6 How do you identify and control RISK in the excipient supply chain? For the RISK Not going to see the full picture from a certificate of analysis a questionnaire a label stating USP inspection on receipt lab analysis audit of the manufacturer/distributor purchasing contract Supplier Qualification is the foundation for controlling and managing risk in the supply chain.

7 The journey from the manufacturing site

8 Who is in the supply chain? The owner s of the product along the way are responsible for the product and act according to their own advantage which may be different than the end users requirements. Shipping companies, tanking terminals, cross-dock sites, warehouses, and repackaging operations all work under the contract of the owner of the product. In the absence of specific directives the handler will apply their common practices.

9 Supplier Qualification is a discovery process between the user and maker of the excipient. Knowing the true risk is the first step in preventing programs that look good on paper but offer only a false sense of security. You can not manage risk you do not see.

10 Qualification provides information for Supply Chain Controls Excipient Pedigree Do you know where your ingredients are produced? Do you know how they were distributed? What evidence do you have which demonstrates this? More than One Up and One Down in supply chain is needed! What is your weakest link..?

11 Using an excipient without knowing the manufacturing location and its path to your front door is like using a toothbrush you find laying in a public restroom.

12 More than just sourcing location You can leap from a building any where in the world and the results will be the same. Qualification of suppliers that use good manufacturing & distribution practices make excipients safe, not manufacturing locations!

13 Know your supply chain Starting point of an excipient qualification program IPEC Excipient Qualification Guide Ask your supplier and follow the chain to the manufacturer IPEC-Americas Standardized Excipient Information Protocol Excipient Pedigree White Paper Know the history and reputation of each party Understand the practices followed at each step IPEC-PQG GMP Guide for Pharmaceutical Excipients IPEC Good Distribution Practices Guide IPEC-Americas Significant Change Guide IPEC-Americas Certificate of Analysis Guide IPEC Stability Guide Match risk and controls IPEC Standardized Quality Agreement Template

14 Excipient Qualification is like a marriage Need to know that maker and user - Are compatible Can satisfy Will be supportive Will be reliable Will understand Will contribute Will communicate

15 Not like a marriage Your supplier will have many partners Many excipient suppliers have their primary business in food, cosmetic, or industrial markets Products targeted at Food, Beverage, Industrial, and Cosmetic Small fraction of Main Production Volumes for excipient Varying degrees of dedicated R&D related to excipient uses Specifications-driven by main market (usually not Pharma) Global Market and Manufacturing Base Some excipient manufacturers only ship bulk or full truck load thus making repacking or shipping by a distributor necessary Qualification must achieve mutual agreement

16 Before and after Before ISO9001:2000 Q10 After The squeezing of the supply chain in the late 1980s and the 1990s Quality Management Principles ISO/TC176/SC2 1997/05/29

17 Quality Management Principles Customer-Focused Organization Leadership Involvement of People Process Approach Systems Approach to Management Continual Improvement Factual approach to decision making Mutually Beneficial supplier relationships

18 IPEC Excipient Qualification Guide The Guide is a consensus document between IPEC-Americas and IPEC Europe. It is a Guide, not a regulation but an aid to help users and makers find reach understanding and agreement The Guide represents sound advice for the introduction and assessment of new excipients or new sources of existing excipients. It is not necessary to follow the Guide to the letter, or the precise order of steps. Three phases of qualification The Excipient Supplier s Process The User s Process The Negotiation Process

19 Phase 1: Excipient Supplier s Process Section 2: General Guidance Differentiation of Excipient Manufacture Preliminary Marketing Decision Regulatory Assessment Safety New Compendial requirements Excipient master files Harmonization Manufacture and Packaging

20 Phase 1: Excipient Supplier s Process Section 3: Excipient Development and Specification Process Excipient Consistency and Control Performance Indicators Production Specifications and Master Batch Record Marketing Materials Customer Feedback Post Launch Confidentiality

21 Phase 2: The User s Process Section 4: Assessment, Selection and Specification Process Project initiation New Formulation Development Selecting the Excipients Selecting the Supplier Regulatory Assessment Refining the Excipient list Formulation Design, Development and Optimization Alternate Excipient Sourcing

22 Phase 3: The Negotiation Process Section 5: Negotiating the Supply Review of User Requirements Quality Agreement Modification of Requirements Potential solutions Lot selection Manufacture to order Other approaches In-house processing Reformulation Custom manufacture

23 Flow Diagrams The flow diagrams are intended to augment the explanation given in the body of the Guide. Three interlinked flow diagrams Phase 1: The Excipient Manufacture s Process Phase 2: The Excipient User s Process Phase 3: The Negotiations The flow charts each cover more than one page: (Phase 1: 2 pages, Phase 2: 3 pages, Phase 3: 3 pages)

24 How do you know your excipients were made following GMPs distributed following GDP? Receipt testing? Not practical to test for everything Sampling is still just a sample Testing tells you about this lot not the next Ask the supplier? Good start but who are you asking? Are the answers the whole story? Ask the Government? Good start but absence of information is not conformation that all is well Audit the supplier? 24

25 Why do we audit? Primary Goal Document what is right Collect objective evidence to show the quality system is functioning as designed and the desired outcome is being achieved Show the system is suitable, adequate, and effective Secondary outcome Identify opportunities To reduce risk and improve supply To identify areas that do not add value To identify process that do not meet their target Provide management information to make fact based decisions regarding the quality system

26 Help bring your suppliers up You came all this way to get evidence to support in support of qualification Why not support the supplier Language differences exist between the chemical and pharma industries You came all this way to get some information don t let the words get in the way of finding out what s going on IPEC Guides help with translation

27 Conclusions Qualification is necessary across the entire supply chain from manufacture to end user The IPEC Excipient Qualification Guide is the document that links together all other IPEC Guides. The guide helps users and makers build mutually beneficial relationships The guide cannot cover all possible scenarios. Users of the guide should decide for themselves what is relevant to their needs. Good qualification process makes for a happy marriage IPEC Guides help

28 Resources IPEC Download IPEC Guidance documents Available for free (do need to register)

29 THANK YOU! Special thanks to: Janeen Skutnik Pfizer / IPEC-Americas Irwin Silverstein IPEA Dave Schoneker Colorcon/IPEC-Americas Chris Moreton FinnBritt Consulting dale.carter@huber.com William Dale Carter Director of Global Quality JM Huber, Engineered Materials Silica 1000 Parkwood Circle Suite 1000 Atlanta, GA Phone

Excipient GMPs and The Global Certification Project

Excipient GMPs and The Global Certification Project Excipient GMPs and The Global Certification Project William Dale Carter IPEC Americas Chair-Elect & GMP Committee Chair Excipient Fest Educational Session Day 2 May 6, 2010 www.ipec-americas.org 1 A variety

More information

Holding Your Suppliers Accountable

Holding Your Suppliers Accountable Holding Your Suppliers Accountable What Defines an Ingredient Supplier of Choice? David R. Schoneker Director of Global Regulatory Affairs dschoneker@colorcon.com 0 Supply Chain Accountability Why and

More information

Multiple stakeholders; one objective. Atypical Actives Industry Perspective. USP Excipients Stakeholder Forum November 29, 2017

Multiple stakeholders; one objective. Atypical Actives Industry Perspective. USP Excipients Stakeholder Forum November 29, 2017 Atypical Actives Industry Perspective USP Excipients Stakeholder Forum November 29, 2017 Multiple stakeholders; one objective. Priscilla Zawislak Chair, IPEC-Americas pzawislak@dow.com International Pharmaceutical

More information

18.H Questionnaire for preparing GMP-inspections

18.H Questionnaire for preparing GMP-inspections Questionnaire for preparing -inspections Questionnaire for preparing -inspections Here you will find answers to the following questions: What questions are typically asked during inspections based on current

More information

The IPEC Excipient Stability Program Guide

The IPEC Excipient Stability Program Guide The IPEC Excipient Stability Program Guide 2010 This document represents voluntary guidance for the pharmaceutical excipient industry and the contents should not be interpreted as regulatory requirements.

More information

Qualification of Excipients for Pharmaceutical Use

Qualification of Excipients for Pharmaceutical Use Qualification of Excipients for Pharmaceutical Use 2008 Copyright 2008 The International Pharmaceutical Excipients Council FOREWORD IPEC is an international industry association formed in 1991 by manufacturers

More information

GxP Auditing, Remediation, and Staff Augmentation

GxP Auditing, Remediation, and Staff Augmentation GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing 8

More information

SQAS/ESAD. Guidelines

SQAS/ESAD. Guidelines SQAS/ESAD Guidelines November 2012 NOTICE OF TERMS OF USE While the advice given in these guidelines has been developed using the best information currently available, it is intended purely as guidance

More information

Volume 1 Cases 1-4. Managing Perishable. Shelf Life. Expiration Dates and Planning Transportation management

Volume 1 Cases 1-4. Managing Perishable. Shelf Life. Expiration Dates and Planning Transportation management REAL WORLD SCENARIOS Volume 1 Cases 1-4 Managing Perishable Items Shelf Life Expiration Dates and Planning Calculations Batch Attributes Perishable Warehouse/ Transportation management Managing Perishable

More information

GxP Auditing, Remediation, and Staff Augmentation

GxP Auditing, Remediation, and Staff Augmentation GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 5 GLP Auditing 6 Pharmacovigilance Auditing 6 Vendor/Supplier Auditing 7

More information

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations Page 1 of 8 Inspections, Compliance, Enforcement, and Criminal Investigations Lupin Limited 5/7/09 Department of Health and Human Services Public Health Service Food and Drug Administration CENTER FOR

More information

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf Textvergleich Verglichene Dokumente MEDIA3917.pdf ICH_Q10_Step4.pdf Übersicht 2270 Wort/Wörter hinzugefügt 1338 Wort/Wörter gelöscht 3558 Wort/Wörter übereinstimmend 157 Block/Blöcke übereinstimmend Blättern

More information

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Medical Device Product Questionnaire This questionnaire is used to collect information from vendors with regards to medical devices that fall in any of the

More information

EXCiPACT is a registered trademark

EXCiPACT is a registered trademark EXCiPACT is a registered trademark The EXCiPACT standards in this document are copyright protected by EXCiPACT asbl. The EXCiPACT standards may not be reproduced, stored in a retrieval system or transmitted

More information

Q10 PHARMACEUTICAL QUALITY SYSTEM

Q10 PHARMACEUTICAL QUALITY SYSTEM Q10 PHARMACEUTICAL QUALITY SYSTEM This draft guidance, when finalized, will represent the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights

More information

The Risk Management + Design Controls Connection: What Device Makers Need to Know

The Risk Management + Design Controls Connection: What Device Makers Need to Know !!! The Risk Management + Design Controls Connection: What Device Makers Need to Know Jon Speer Founder & VP of QA/RA greenlight.guru Table of Contents 1 Intended Use & User Needs 6 Verification, Validation,

More information

SQL*LIMS P4 Plug & Play Pharma Package

SQL*LIMS P4 Plug & Play Pharma Package SQL*LIMS P4 PLUG & PLAY PHARMA PACKAGE SQL*LIMS P4 Plug & Play Pharma Package Reduces complexity, accelerates deploying industry best practice workflows, simplifies IT Get up and running fast with a fully

More information

How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S)

How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S) How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S) ASQ Northeast Pharmaceutical GMP/Quality Conference January

More information

Medical Device Purchasing Controls Challenges of Compliance in a World Market June, 2013 OMTEC

Medical Device Purchasing Controls Challenges of Compliance in a World Market June, 2013 OMTEC Medical Device Purchasing Controls Challenges of Compliance in a World Market June, 2013 OMTEC - 2013 Quality Business Acceptance Activities 1 ..FDA Across the Globe.. 2 ..Warning Letters and FDA 483 update..

More information

Quality Agreements and Managing Contract Supplier Quality

Quality Agreements and Managing Contract Supplier Quality Quality Agreements and Managing Contract Supplier Quality American Society for Quality Lloyd Bailey November 3, 2005 Service Mark of The Dow Chemical Company TM Trademark of The Dow Chemical Company Abstract

More information

Di Renzo Regulatory Affairs ROME - MILAN - LONDON

Di Renzo Regulatory Affairs ROME - MILAN - LONDON Di Renzo Regulatory Affairs ROME - MILAN - LONDON Di Renzo Regulatory Affairs In 1985, Di Renzo Regulatory Affairs began its regulatory consulting for medicines for human and veterinary use, food and dietary

More information

NSF International Standard / American National Standard. NSF/IPEC/ANSI Good Manufacturing Practices (GMP) for Pharmaceutical Excipients

NSF International Standard / American National Standard. NSF/IPEC/ANSI Good Manufacturing Practices (GMP) for Pharmaceutical Excipients NSF International Standard / American National Standard NSF/IPEC/ANSI 363-2016 Good Manufacturing Practices (GMP) for Pharmaceutical Excipients NSF International, an independent, notfor-profit, non-governmental

More information

Annex 14 WHO guidelines for drafting a site master file 136

Annex 14 WHO guidelines for drafting a site master file 136 World Health Organization WHO Technical Report Series, No.961, 2011 Annex 14 WHO guidelines for drafting a site master file 136 1. Introduction 2. Purpose 3. Scope 4. Content of site master fi le Appendix

More information

BRC Food Safety Management System Implementation Workbook

BRC Food Safety Management System Implementation Workbook We have written this workbook to assist in the implementation of your BRC food safety management system. The workbook is divided into 8 steps that are designed to assist you in implementing your food safety

More information

UNICEF Quality Assurance in the procurement of medicines

UNICEF Quality Assurance in the procurement of medicines UNICEF Quality Assurance in the procurement of medicines Peter S. Jakobsen 30 October 2006 Quality Assurance Centre SUPPLY DIVISION Today s presentation addresses 3 questions: How is UNICEF involved in

More information

Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C.

Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Manufacturing Breakout Session 1 Survey Results: Drug Product Manufacturing

More information

Quality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits

Quality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits Quality Assurance QA 601.01 STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature and Date) Approval: Frederick

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY  ISSN Review Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INTRODUCTION AND GENERAL OVERVIEW OF PHARMACEUTICAL PROCESS VALIDATION: A REVIEW Pandita Rachna* 1, Rana A C

More information

Pharmaceutical Development (Drug Substance & Drug Product) for Visceral Leishmaniasis candidate DNDI-6148

Pharmaceutical Development (Drug Substance & Drug Product) for Visceral Leishmaniasis candidate DNDI-6148 Request for Proposal Pharmaceutical Development (Drug Substance & Drug Product) for Visceral Leishmaniasis candidate DNDI-6148 Dated: October 12 th 2015 Page 1 Table of Contents 1. PURPOSE... 3 2. RFP

More information

Industry Perspective on Manufacturing in Early Development

Industry Perspective on Manufacturing in Early Development Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical

More information

INFORMATION REQUIRED FROM PHARMACEUTICAL FIRMS FOR REGISRATION

INFORMATION REQUIRED FROM PHARMACEUTICAL FIRMS FOR REGISRATION INFORMATION REQUIRED FROM PHARMACEUTICAL FIRMS FOR REGISRATION Part A: Details of the market Authorization holder (local agent)- 1. Name of Company: 2. Address and contact details of the company : 3. a)

More information

Taking a Leap Toward Global Supply Chain Efficiency - Part II

Taking a Leap Toward Global Supply Chain Efficiency - Part II Taking a Leap Toward Global Supply Chain Efficiency - Part II 2 Supply Chain Brochure - Part II INTRODUCTION Pharmaceutical manufacturers face a number of challenges in the production and delivery of medicinal

More information

ISO 22000:2005 Standard INTERNATIONAL STANDARDS REGISTRATIONS

ISO 22000:2005 Standard INTERNATIONAL STANDARDS REGISTRATIONS ISO 22000:2005 Standard Food Safety Management System INTERNATIONAL STANDARDS REGISTRATIONS 3.1 FOOD SAFETY concept that food will not cause harm to the consumer when it is prepared and/or eaten according

More information

GxP Auditing, Remediation, and Quality System Resourcing

GxP Auditing, Remediation, and Quality System Resourcing GxP Auditing, Remediation, and Quality System Resourcing TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing

More information

GMP On Site Series. GMP Essentials

GMP On Site Series. GMP Essentials GMP On Site Series GMP Essentials GMP Basics Objectives 1. State the critical definitions of the pharmaceutical industry. 2. Describe the law as it applies to various critical functions. 3. State the history

More information

LEGAL REQUIREMENTS FOR STABILITY

LEGAL REQUIREMENTS FOR STABILITY BY DR. A.V.PRABHU LEGAL REQUIREMENTS FOR STABILITY 21 CFR 211.166- STABILITY TESTING GMP To assess stability characteristics to determine storage conditions and expiration dates. Written stability program

More information

Harmonizing FDA Regulation and the Practice of Pharmacy: Challenges and Opportunities. Plus an update on PET Drug User Fees

Harmonizing FDA Regulation and the Practice of Pharmacy: Challenges and Opportunities. Plus an update on PET Drug User Fees Harmonizing FDA Regulation and the Practice of Pharmacy: Challenges and Opportunities Plus an update on PET Drug User Fees Michael Nazerias - Vice President, RA/QA PETNET Solutions, Inc. (a Siemens Company)

More information

Strategies for Risk Based Validation of Laboratory Systems

Strategies for Risk Based Validation of Laboratory Systems Strategies for Risk Based Validation of Laboratory Systems Video Web Seminar September 23, 2004 Ludwig Huber E-mail: ludwig_huber@agilent.com Today s Agenda Background information: why risk assessment,

More information

GMPs: Distribution Centers

GMPs: Distribution Centers SkillsPlus International Inc. The On-Site Series GMPs: Distribution Centers Learn to apply the GMP regulations as they relate to distribution center operations! FDA Past, Present, and Future and opener

More information

The IPEC Risk Assessment Guide for Pharmaceutical Excipients. Part 1 Risk Assessment for Excipient Manufacturers

The IPEC Risk Assessment Guide for Pharmaceutical Excipients. Part 1 Risk Assessment for Excipient Manufacturers The IPEC Risk Assessment Guide for Pharmaceutical Excipients Part 1 Risk Assessment for Excipient Manufacturers First Version 2017 This document represents voluntary guidance for the pharmaceutical excipient

More information

EU and FDA GMP Regulations: Overview and Comparison

EU and FDA GMP Regulations: Overview and Comparison THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational

More information

EVANS CAPACITOR COMPANY

EVANS CAPACITOR COMPANY DISTRIBUTION LIST: Location Book # Quality Manager 0001 President 0002 CEO 0003 Engineering Manager 0004 Production Manager 0005 Office Manager 0006 Page 1 of 33 REV A 11/18/03 TABLE OF CONTENTS Page Distribution

More information

CHALLENGES OF GLOBAL CLINICAL TRIAL SUPPLY SOURCING SOME SPECIFICS FOR EMERGING MARKETS

CHALLENGES OF GLOBAL CLINICAL TRIAL SUPPLY SOURCING SOME SPECIFICS FOR EMERGING MARKETS Clinical Trial Supply 28 th 29 th October 2014 Princeton, NJ - USA CHALLENGES OF GLOBAL CLINICAL TRIAL SUPPLY SOURCING SOME SPECIFICS FOR EMERGING MARKETS 1 Agenda The challenges associated with various

More information

Conducting Supplier Audits: Ensure Validation Compliance

Conducting Supplier Audits: Ensure Validation Compliance Conducting Supplier Audits: Ensure Validation Compliance Presented by: Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Outline Why

More information

ISO 22000:2005 SYSTEMKARAN ADVISER & INFORMATION CENTER SYSTEM KARAN ADVISER & INFORMATION CENTER FOOD SAFETY MANAGEMENT SYSTEM ISO 22000:2005

ISO 22000:2005 SYSTEMKARAN ADVISER & INFORMATION CENTER SYSTEM KARAN ADVISER & INFORMATION CENTER FOOD SAFETY MANAGEMENT SYSTEM ISO 22000:2005 SYSTEM KARAN ADVISER & INFORMATION CENTER FOOD SAFETY MANAGEMENT SYSTEM ISO 22000:2005 WWW.SYSTEMKARAN.ORG 1 www.systemkaran.org Foreword... 6 Introduction... 7 Food safety management systems Requirements

More information

SQF 2000 Food Safety Management System Implementation Workbook

SQF 2000 Food Safety Management System Implementation Workbook This comprehensive SQF 2000 Food Safety and Quality Management System package contains everything you will need to achieve SQF 2000 Certification. We have written this workbook to assist in the implementation

More information

GOOD TRADE AND DISTRIBUTION PRACTICES FOR PHARMACEUTICAL STARTING MATERIALS. REVISION

GOOD TRADE AND DISTRIBUTION PRACTICES FOR PHARMACEUTICAL STARTING MATERIALS. REVISION July 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 GOOD TRADE AND DISTRIBUTION PRACTICES FOR PHARMACEUTICAL STARTING MATERIALS.

More information

Feed Quality Assurance and Certification Programs. Representing the Total Feed Industry

Feed Quality Assurance and Certification Programs. Representing the Total Feed Industry Feed Quality Assurance and Certification Programs Quality Programs ISO 22000 Food Industry HAACP System Certification Program Comprehensive Quality Assurance Programs New US Food Safety Laws Animal Feed

More information

HACCP audit checklist

HACCP audit checklist Requirement HACCP audit checklist Prerequisite Program Management Commitment 1. Senior management ensures that the responsibilities and authorities are defined and communicated within the company Internal

More information

Proven to Make Your Operations More Accurate, Efficient, Profitable and Audit-Ready

Proven to Make Your Operations More Accurate, Efficient, Profitable and Audit-Ready Proven to Make Your Operations More Accurate, Efficient, Profitable and Audit-Ready Scale-Integrated Chemical Inventory Management Software Suite 4 Warehouse Management System (WMS) 4 Manufacturing Execution

More information

Requirements for Industry PIF. Regional Training on Product Information File (PIF) Product Information File (PIF)

Requirements for Industry PIF. Regional Training on Product Information File (PIF) Product Information File (PIF) Regional Training on Product Information File (PIF) 10-11 11 June 2007 Vientiane LAO PDR Product Information File (PIF) Requirements for Industry PIF The Company or Person placing a cosmetic product in

More information

Global Compliance Trends and Warning Letters

Global Compliance Trends and Warning Letters Contact: Charles Lu Director, Quality Carlsbad Tech Phone: (760) 431-8284 Fax: (203) 555-0101 5928 Farnsworth Ct Carlsbad, CA, 92008 www.carlsbadtech.com Global Compliance Trends and Warning Letters Governance

More information

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Finished Pharmaceutical Product Questionnaire This questionnaire is used to collect information from vendors with regards to finished pharmaceutical products

More information

Responding to an FDA 483

Responding to an FDA 483 Responding to an FDA 483 Jim Melancon VP, Associate General Counsel BioScrip, Inc. Marc Stranz, PharmD Healthcare Consultant Disclosure The speakers declare no conflicts of interest or financial interest

More information

USP General Chapter <1079> Pharmacopeia Forum. for Drug Products

USP General Chapter <1079> Pharmacopeia Forum. for Drug Products USP General Chapter Pharmacopeia Forum Good Storage and Transportation Practices for Drug Products IATA Vancouver/March 8-12, 2010 Mary Foster, PharmD USP Expert Committee Member, 2005-2010 2010

More information

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Ref. Ares(2015)4234460-12/10/2015 Medicinal products quality, safety and efficacy Brussels, 12 October 2015 EudraLex Volume 4 EU Guidelines

More information

Christian Gausepohl, Frank Böttcher. GMP Focus. Managing Contract Manufacturers and Testing Labs. PDF Download. Excerpt from the GMP MANUAL

Christian Gausepohl, Frank Böttcher. GMP Focus. Managing Contract Manufacturers and Testing Labs. PDF Download. Excerpt from the GMP MANUAL Christian Gausepohl, Frank Böttcher GMP Focus Managing Contract Manufacturers and Testing Labs PDF Download Excerpt from the GMP MANUAL Bibliographic Data of the Deutsche Nationalbibliothek: http://dnb.ddb.de

More information

Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES

Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES William Garvey and Associates LLC 2016 Introduction About your instructor William (Bill) Garvey Important regulations and events Good Manufacturing

More information

Combination Products Part 4 Compliance and Implementation at multi-site Network

Combination Products Part 4 Compliance and Implementation at multi-site Network Combination Products Part 4 Compliance and Implementation at multi-site Network Vijay Damodaran Eli Lilly & Company September 27, 2017 Contents Key cgmp requirements for combination products How to perform

More information

Supplier Assurance Program. CBE Pty Ltd

Supplier Assurance Program. CBE Pty Ltd Supplier Assurance Program CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without its express written permission.

More information

The Joint IPEC PQG Good Manufacturing Practices Audit Guide

The Joint IPEC PQG Good Manufacturing Practices Audit Guide The Joint IPEC PQG Good Manufacturing Practices Audit Guide FOR PHARMACEUTICAL EXCIPIENTS Copyright 2007 The International Pharmaceutical Excipients Council and Copyright 2007 Pharmaceutical Quality Group

More information

PCI Pharmaceutical Consulting

PCI Pharmaceutical Consulting PCI Pharmaceutical Consulting The Role of the QP: before & after Annex 16 Presented by: Karen Ginsbury For IFF, Denmark March 2016 Responsibility Authority Responsibility Authority Having the duty to perform

More information

BEGINNER S GUIDE TO ISO 9001 : Quality Management System Requirements Explained

BEGINNER S GUIDE TO ISO 9001 : Quality Management System Requirements Explained BEGINNER S GUIDE TO ISO 9001 : 2015 Quality Management System Requirements Explained What is ISO 9001 : 2015? Why use it? ISO 9001 is an internationally recognised standard in quality. It is a guide to

More information

How to perform PPAP Level 1 Level 2 Level 3 Level 4 Level 5

How to perform PPAP Level 1 Level 2 Level 3 Level 4 Level 5 How to perform PPAP The process of completing a PPAP submission is complex. This detailed process is a collection of key elements that must be completed to verify that the production process will produce

More information

Reference Standard Characterization. Steve Lane. General Manager, NSF Reference Standards.

Reference Standard Characterization. Steve Lane. General Manager, NSF Reference Standards. Reference Standard Characterization Steve Lane General Manager, NSF Reference Standards www.nsf-rs.org Regulatory Bodies will require that an Excipient: Be safe in the amount or dose used Meet applicable

More information

1 General Information Supplier:

1 General Information Supplier: 1 General Information Supplier: Company Address Street Postal code and City Country Phone Fax Contact Person Function Department E-Mail Quality Management Quality Manager Phone Fax E-Mail The information

More information

TECTURA LIFE SCIENCES HIGHLIGHTS

TECTURA LIFE SCIENCES HIGHLIGHTS HIGHLIGHTS BATCH AND SERIAL NUMBER MANAGEMENT QUALITY CONTROL VENDOR RATING ELECTRONIC SIGNATURE AND AUDIT TRAIL R&D MODULE MANAGEMENT OF ACTIVE INGREDIENTS SEQUENCE PLANNING MOBILE SCANNER INTEGRATION

More information

FINAL DOCUMENT. International Medical Device Regulators Forum. Medical Device Regulatory Audit Reports

FINAL DOCUMENT. International Medical Device Regulators Forum. Medical Device Regulatory Audit Reports FINAL DOCUMENT International Medical Device Regulators Forum Title: Authoring Group: Medical Device Regulatory Audit Reports IMDRF MDSAP Working Group Date: 2 October 2015 Toshiyoshi Tominaga, IMDRF Chair

More information

Updates on Quality Metrics - Industry Perspectives Dan Snider Vice President, Research and Development Mylan Inc.

Updates on Quality Metrics - Industry Perspectives Dan Snider Vice President, Research and Development Mylan Inc. GPhA/FDA FALL TECHNICAL CONFERENCE Updates on Quality Metrics - Industry Perspectives Dan Snider Vice President, Research and Development Mylan Inc. Disclaimer This presentation contains a summary of the

More information

Guidelines for Process Validation of Pharmaceutical Dosage Forms

Guidelines for Process Validation of Pharmaceutical Dosage Forms Guidelines for Process Validation of Pharmaceutical Dosage Forms Version 2.1 Date issued 21/02/2010 Date of implementation 21/05/2010 31 August 2010 Page 1 of 20 Guidelines for Process Validation of Pharmaceutical

More information

Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document

Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document March 2017 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 1 ICH Q7 - Questions

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.

More information

Elemental Impurities: An Industry Perspective

Elemental Impurities: An Industry Perspective Elemental Impurities: An Industry Perspective Ernest Parente, PhD Mallinckrodt Pharmaceuticals May 17, 2016 2016 GPhA CMC Workshop Overview Risk Assessment The Supplier Interface The Contractor Interface

More information

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU Numerous articles are available comparing the current and previous EU Code of GMP Chapter 4: Documentation, but no comparison exists between

More information

Partner with the Global Leader in Drug Delivery Systems

Partner with the Global Leader in Drug Delivery Systems 3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems Northridge, CA, USA Manufacturing Facility Experts at Commercializing Innovation 3M: Transforming New Ideas into Thousands

More information

Hazard Analysis and Critical Control Point The Almond Board of California. Overview. Definitions

Hazard Analysis and Critical Control Point The Almond Board of California. Overview. Definitions Hazard Analysis and Critical Control Point The Almond Board of California Overview Hazard Analysis Critical Control Point (HACCP) is the final stage of an integrated, proactive food safety program targeting

More information

Audits and Inspections

Audits and Inspections Audits and Inspections Dr. Dirk Feldmann 06. November 2017 First we take measurements, then we take measures. TECHNICAL Content Audits and inspections Types of audits EHS Challenges and chances Preparation

More information

Agilent Resources for Workflow Compliance MEASURING ELEMENTAL IMPURITIES IN PHARMACEUTICAL MATERIALS

Agilent Resources for Workflow Compliance MEASURING ELEMENTAL IMPURITIES IN PHARMACEUTICAL MATERIALS Agilent Resources for Workflow Compliance MEASURING ELEMENTAL IMPURITIES IN PHARMACEUTICAL MATERIALS AGILENT SOLUTIONS USP / & ICH Q3D Implementing Elemental Impurities Tests in the Pharmaceutical

More information

Introduction to CMC Regulatory Affairs

Introduction to CMC Regulatory Affairs Introduction to CMC Regulatory Affairs Bharathi Mamidipudi Regulatory Affairs Consultant II Syner-G Pharma Consulting, LLC Northeastern University, Boston November 10, 2016 My Background Experience ~4

More information

Quality Manual. Index

Quality Manual. Index This quality policy manual is for the use of, its Clients, Vendors, and the appropriate Regulatory Agencies. Unauthorized duplication or transfer to others is prohibited. Index Authorization... 3 Introduction...

More information

Questionnaire Layout:

Questionnaire Layout: Raw Material Supplier Questionnaire Introduction: This questionnaire has been developed by the EHPM quality working group. It combines work carried out by EHPM various national associations in developing

More information

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions) 21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software

More information

Soft Paraffins BP/EP, Liquid & Light Liquid Paraffins BP/EP (White Oils)

Soft Paraffins BP/EP, Liquid & Light Liquid Paraffins BP/EP (White Oils) FUCHS Pharmaceutical and Cosmetics Products Innovative solutions need experienced advice FUCHS Lubricants (UK) plc Special Products Team will be glad to advise on the right product for each application

More information

QUALITY MANUAL DISTRIBUTION. Your Logo Here. Page 1 1 of 57. Rev.: A

QUALITY MANUAL DISTRIBUTION. Your Logo Here. Page 1 1 of 57. Rev.: A Page 1 1 of 57 President Design Engineering Production Production Engineering Materials Control Purchasing Service Marketing Sales Contracts Human Resources Quality Assurance Quality Control Production

More information

The largest network of harmonized bio/ pharmaceutical GMP product testing labs worldwide, Eurofins BioPharma Product Testing enables companies to

The largest network of harmonized bio/ pharmaceutical GMP product testing labs worldwide, Eurofins BioPharma Product Testing enables companies to The largest network of harmonized bio/ pharmaceutical GMP product testing labs worldwide, Eurofins BioPharma Product Testing enables companies to advance candidates from development through commercialization

More information

Good Clinical Practice (GCP): how does a laboratory that supports a clinical trial ensure compliance with these Regulations

Good Clinical Practice (GCP): how does a laboratory that supports a clinical trial ensure compliance with these Regulations Good Clinical Practice (GCP): how does a laboratory that supports a clinical trial ensure compliance with these Regulations 9th edition of Synevo Clinical Research Symposium. 17 th November 2017 Bucharest.

More information

Moving from ISO/TS 16949:2009 to IATF 16949:2016. Transition Guide

Moving from ISO/TS 16949:2009 to IATF 16949:2016. Transition Guide Moving from ISO/TS 16949:2009 to IATF 16949:2016 Transition Guide IATF 16949:2016 - Automotive Quality Management System - Transition Guide An effective Quality Management System is vital for organizations

More information

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1 AAMI s White Paper Comparison of 21 CFR Part 820 to ISO 13485:2016 February 2017 AUTHORS Seb Clerkin, GMP Advisory Services Nicola Martin, Owner, Nicola Martin Consulting Jack Ward, Owner, Ward Sciences

More information

MEASURE FOR MEASURE: QUALITY METRICS

MEASURE FOR MEASURE: QUALITY METRICS MEASURE FOR MEASURE: QUALITY METRICS PDA Midwest Chapter Dinner Meeting, Northbrook, IL-9 November 2017 Felicia Ford-Rice, Director, Strategic Compliance 2017 PAREXEL INTERNATIONAL CORP. AGENDA Robust

More information

QMS CO-ORDINATOR & GENERAL PROCEDURES:-

QMS CO-ORDINATOR & GENERAL PROCEDURES:- 1. QMS CO-ORDINATOR & GENERAL PROCEDURES:- (1) How do you measure effectiveness of system for working of your company? How do you collect necessary information for the same? Are you getting information

More information

FDA 21 CFR Part 820 vs. ISO 13485:2016 Comparison Table created by greenlight.guru

FDA 21 CFR Part 820 vs. ISO 13485:2016 Comparison Table created by greenlight.guru FDA 21 CFR Part 820 vs. ISO 13485:2016 Comparison Table created by greenlight.guru FDA QSR (21 CFR Part 820) ISO 13485:2016 820.1 Scope 1 Scope 2 Normative References 820.3 Definitions 3 Terms and Definitions

More information

D107: DEMO OF ISO: FOOD SAFETY DOCUMENT KIT Price 360 USD

D107: DEMO OF ISO: FOOD SAFETY DOCUMENT KIT Price 360 USD Chapter-1.0 CONTENTS OF ISO 22000 DOCUMENT KIT (More than 100 document files) A. The entire Document kit has 5 main directories as below. Sr. No. List of Directory Document of Details 1. Food Safety Manual

More information

FUCHS Pharmaceutical and Cosmetics Products. Soft Paraffins BP/EP, Liquid & Light Liquid Paraffins BP/EP (White Oils)

FUCHS Pharmaceutical and Cosmetics Products. Soft Paraffins BP/EP, Liquid & Light Liquid Paraffins BP/EP (White Oils) FUCHS Pharmaceutical and Cosmetics Products Soft Paraffins BP/EP, Liquid & Light Liquid Paraffins BP/EP (White Oils) FUCHS has over 40 years experience in the production of White & Yellow Soft Paraffins

More information

An Investigation of the Important Project Management Knowledge Areas in the Life Sciences Sector

An Investigation of the Important Project Management Knowledge Areas in the Life Sciences Sector An Investigation of the Important Project Management Knowledge Areas in the Life Sciences Sector D.V. Auman Hospira Adelaide, SA, Australia Abstract The application of project management knowledge and

More information

Correspondence Between ISO 13485:2016 and 21 CFR Part 820 QMS Requirements

Correspondence Between ISO 13485:2016 and 21 CFR Part 820 QMS Requirements Correspondence Between and 21 CFR Part 820 QMS Requirements 10411 Corporate Drive, Suite 102, Pleasant Prairie, WI 53158 262.842.1250 262.842.1240 info@rcainc.com rcainc.com 2 4 Quality Management System

More information

VALIDATION OF RAW MATERIALS

VALIDATION OF RAW MATERIALS Seminar On VALIDATION OF RAW MATERIALS By S.Rajesh kumar M.Pharmacy I SEM Department of Industrial pharmacy University college of pharmaceutical sciences Kakatiya university CONTENTS INTRODUCTION TO VALIDATION

More information

Good Distribution Practice and Supply Chain Risk Evaluation

Good Distribution Practice and Supply Chain Risk Evaluation Good Distribution Practice and Supply Chain Risk Evaluation Who we are - Exelsius An international consultancy established in 2007 bringing cross-sector expertise and skills into a range of services designed

More information

THE VALUE OF DISCRETE-EVENT SIMULATION IN COMPUTER-AIDED PROCESS OPERATIONS

THE VALUE OF DISCRETE-EVENT SIMULATION IN COMPUTER-AIDED PROCESS OPERATIONS THE VALUE OF DISCRETE-EVENT SIMULATION IN COMPUTER-AIDED PROCESS OPERATIONS Foundations of Computer Aided Process Operations Conference Ricki G. Ingalls, PhD Texas State University Diamond Head Associates,

More information

MINIMUM REQUIREMENTS FOR A VENDOR

MINIMUM REQUIREMENTS FOR A VENDOR MINIMUM REQUIREMENTS FOR A VENDOR When outsourcing the production of sterile products the first step in vendor evaluation is to see if they meet the minimum requirements. We ve developed a group of questions

More information

22 January Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm Rockville, MD 20852

22 January Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm Rockville, MD 20852 22 January 2009 Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 SUBMISSION OF COMMENTS, DOCKET NO. FDA-2008-D-0559 Dear Sir or Madam:

More information